ACLARA and Amersham Biosciences Announce Joint Marketing and Service Agreement for Use of eTag Assay System on MegaBACE
04-Apr-2003 -
MOUNTAIN VIEW, Calif. & PISCATAWAY, NJ. - ACLARA BioSciences, Inc. (Nasdaq: ACLA) and Amersham Biosciences, the life sciences business of Amersham plc (LSE,OSE, NYSE:AHM), today announced a joint marketing and service agreement for the purpose of marketing MegaBACE(TM) DNA Analysis Systems from ...
Amersham
cell signaling
consulting
+12